High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$9.1M
$9,090,605
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
STOK
S
Stoke Therapeutics, Inc.
Ticho Barry
• Officer • CHIEF MEDICAL OFFICER
10b5-1 Sell
2026-04-01
$60,029
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • CHIEF MEDICAL OFFICER
10b5-1 Sell
|
2026-04-01 | $60,029 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
10b5-1 Sell
2026-03-20
$20,679
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
10b5-1 Sell
|
2026-03-20 | $20,679 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
10b5-1 SellΔOwn -30.1%
2026-03-20
$292,359
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
10b5-1 SellΔOwn -30.1%
|
2026-03-20 | $292,359 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Ticho Barry
• Officer • CHIEF MEDICAL OFFICER
10b5-1 Sell
2026-03-19
$43,815
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • CHIEF MEDICAL OFFICER
10b5-1 Sell
|
2026-03-19 | $43,815 | S | Form 4 |
|
STOK
M
Stoke Therapeutics, Inc.
Ticho Barry
• Officer • CHIEF MEDICAL OFFICER
Other
2026-03-19
$2,989
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • CHIEF MEDICAL OFFICER
Other
|
2026-03-19 | $2,989 | M | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Hoitt Jason
• Officer • Chief Patient Officer
Sell to CoverΔOwn -14.4%
2026-03-18
$55,122
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • Chief Patient Officer
Sell to CoverΔOwn -14.4%
|
2026-03-18 | $55,122 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Hoitt Jason
• Officer • Chief Patient Officer
Sell to Cover
2026-03-18
$4,419
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • Chief Patient Officer
Sell to Cover
|
2026-03-18 | $4,419 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Ticho Barry
• Officer • CHIEF MEDICAL OFFICER
Sell to Cover
2026-03-18
$3,384
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • CHIEF MEDICAL OFFICER
Sell to Cover
|
2026-03-18 | $3,384 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Ticho Barry
• Officer • CHIEF MEDICAL OFFICER
Sell to Cover
2026-03-18
$15,354
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • CHIEF MEDICAL OFFICER
Sell to Cover
|
2026-03-18 | $15,354 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Ticho Barry
• Officer • CHIEF MEDICAL OFFICER
Sell to CoverΔOwn -12.8%
2026-03-18
$190,831
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • CHIEF MEDICAL OFFICER
Sell to CoverΔOwn -12.8%
|
2026-03-18 | $190,831 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Hoitt Jason
• Officer • Chief Patient Officer
Sell to Cover
2026-03-18
$986
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • Chief Patient Officer
Sell to Cover
|
2026-03-18 | $986 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
2026-03-18
$10,617
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
|
2026-03-18 | $10,617 | S | Form 4 |
| STOK |
Stoke Therapeutics, Inc.
|
CFO
Sell to Cover
|
2026-03-18 | $1,215 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
2026-03-18
$2,365
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
|
2026-03-18 | $2,365 | S | Form 4 |
| STOK |
Stoke Therapeutics, Inc.
|
CFO
Sell to Cover
|
2026-03-18 | $5,468 | S | Form 4 |
| STOK |
Stoke Therapeutics, Inc.
|
CFO
Sell to CoverΔOwn -17.3%
|
2026-03-18 | $67,980 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
Sell to CoverΔOwn -12.6%
2026-03-18
$132,080
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
Sell to CoverΔOwn -12.6%
|
2026-03-18 | $132,080 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Hoitt Jason
• Officer • Chief Patient Officer
Sell to Cover
2026-03-17
$33,820
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • Chief Patient Officer
Sell to Cover
|
2026-03-17 | $33,820 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
2026-03-17
$59,775
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
|
2026-03-17 | $59,775 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
2026-03-17
$81,063
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
|
2026-03-17 | $81,063 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Ticho Barry
• Officer • CHIEF MEDICAL OFFICER
Sell to Cover
2026-03-17
$86,342
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • CHIEF MEDICAL OFFICER
Sell to Cover
|
2026-03-17 | $86,342 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Ticho Barry
• Officer • CHIEF MEDICAL OFFICER
Sell to Cover
2026-03-17
$117,109
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • CHIEF MEDICAL OFFICER
Sell to Cover
|
2026-03-17 | $117,109 | S | Form 4 |
| STOK |
Stoke Therapeutics, Inc.
|
CFO
Sell to Cover
|
2026-03-17 | $30,772 | S | Form 4 |
| STOK |
Stoke Therapeutics, Inc.
|
CFO
Sell to Cover
|
2026-03-17 | $41,710 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Hoitt Jason
• Officer • Chief Patient Officer
Sell to Cover
2026-03-17
$24,965
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • Chief Patient Officer
Sell to Cover
|
2026-03-17 | $24,965 | S | Form 4 |
| STOK |
Stoke Therapeutics, Inc.
|
Director
10b5-1 SellΔOwn -12.5%
|
2026-03-13 | $22,264 | S | Form 4 |
| STOK |
Stoke Therapeutics, Inc.
|
Chair
10b5-1 SellΔOwn -12.2%
|
2026-03-10 | $174,214 | S | Form 4 |
| STOK |
Stoke Therapeutics, Inc.
|
Chair
Other
|
2026-03-10 | $32,945 | M | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Krainer Adrian R.
• Director
10b5-1 SellΔOwn -10.5%
2026-03-10
$1,320,964Large
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Director
10b5-1 SellΔOwn -10.5%
|
2026-03-10 | $1,320,964Large | S | Form 4 |
| STOK |
Stoke Therapeutics, Inc.
|
Director
10b5-1 Sell
|
2026-03-02 | $286,715 | S | Form 4 |
| STOK |
Stoke Therapeutics, Inc.
|
Director
10b5-1 Sell
|
2025-12-05 | $15,923 | S | Form 4 |
| STOK |
Stoke Therapeutics, Inc.
|
Director
10b5-1 Sell
|
2025-12-05 | $52,358 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Ticho Barry
• Officer • CHIEF MEDICAL OFFICER
Sell to Cover
2025-12-05
$52,416
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • CHIEF MEDICAL OFFICER
Sell to Cover
|
2025-12-05 | $52,416 | S | Form 4 |
| STOK |
Stoke Therapeutics, Inc.
|
Director
Sell to Cover
|
2025-12-05 | $199,481 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Ticho Barry
• Officer • CHIEF MEDICAL OFFICER
10b5-1 Sell
2025-12-05
$62,346
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • CHIEF MEDICAL OFFICER
10b5-1 Sell
|
2025-12-05 | $62,346 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
2025-12-05
$31,456
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
|
2025-12-05 | $31,456 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
10b5-1 SellΔOwn -23.1%
2025-12-05
$168,997
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
10b5-1 SellΔOwn -23.1%
|
2025-12-05 | $168,997 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
10b5-1 SellΔOwn -12.9%
2025-12-05
$74,445
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
10b5-1 SellΔOwn -12.9%
|
2025-12-05 | $74,445 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
2025-12-04
$6,075
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
|
2025-12-04 | $6,075 | S | Form 4 |
| STOK |
Stoke Therapeutics, Inc.
|
Director
Sell to Cover
|
2025-12-04 | $160,647 | S | Form 4 |
| STOK |
Stoke Therapeutics, Inc.
|
Director
Sell to Cover
|
2025-12-04 | $38,550 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Ticho Barry
• Officer • CHIEF MEDICAL OFFICER
Sell to Cover
2025-12-04
$42,238
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • CHIEF MEDICAL OFFICER
Sell to Cover
|
2025-12-04 | $42,238 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Ticho Barry
• Officer • CHIEF MEDICAL OFFICER
Sell to Cover
2025-12-04
$10,115
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • CHIEF MEDICAL OFFICER
Sell to Cover
|
2025-12-04 | $10,115 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
2025-12-04
$25,349
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
|
2025-12-04 | $25,349 | S | Form 4 |
|
STOK
M
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
Equity Compensation
2025-12-03
$0
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
Equity Compensation
|
2025-12-03 | $0 | M | Form 4 |
| STOK |
Stoke Therapeutics, Inc.
|
Director
Sell to Cover
|
2025-12-03 | $12,712 | S | Form 4 |
| STOK |
Stoke Therapeutics, Inc.
|
Director
Sell to Cover
|
2025-12-03 | $20,082 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Ticho Barry
• Officer • CHIEF MEDICAL OFFICER
Sell to Cover
2025-12-03
$23,937
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • CHIEF MEDICAL OFFICER
Sell to Cover
|
2025-12-03 | $23,937 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Ticho Barry
• Officer • CHIEF MEDICAL OFFICER
Sell to Cover
2025-12-03
$37,788
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • CHIEF MEDICAL OFFICER
Sell to Cover
|
2025-12-03 | $37,788 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
2025-12-03
$27,244
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
|
2025-12-03 | $27,244 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
2025-12-03
$43,002
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
|
2025-12-03 | $43,002 | S | Form 4 |
| STOK |
Stoke Therapeutics, Inc.
|
Director
Equity Compensation
|
2025-12-03 | $0 | M | Form 4 |
|
STOK
M
Stoke Therapeutics, Inc.
Ticho Barry
• Officer • CHIEF MEDICAL OFFICER
Equity Compensation
2025-12-03
$0
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • CHIEF MEDICAL OFFICER
Equity Compensation
|
2025-12-03 | $0 | M | Form 4 |
| STOK |
Stoke Therapeutics, Inc.
|
Director
Sell to Cover
|
2025-12-02 | $19,540 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
2025-12-02
$26,163
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
|
2025-12-02 | $26,163 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
2025-12-02
$41,860
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
|
2025-12-02 | $41,860 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Ticho Barry
• Officer • CHIEF MEDICAL OFFICER
Sell to Cover
2025-12-02
$22,968
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • CHIEF MEDICAL OFFICER
Sell to Cover
|
2025-12-02 | $22,968 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Ticho Barry
• Officer • CHIEF MEDICAL OFFICER
Sell to Cover
2025-12-02
$36,775
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • CHIEF MEDICAL OFFICER
Sell to Cover
|
2025-12-02 | $36,775 | S | Form 4 |
| STOK |
Stoke Therapeutics, Inc.
|
Director
Sell to Cover
|
2025-12-02 | $12,207 | S | Form 4 |
|
STOK
M
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
Equity Compensation
2025-12-01
$0
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
Equity Compensation
|
2025-12-01 | $0 | M | Form 4 |
| STOK |
Stoke Therapeutics, Inc.
|
Director
Equity Compensation
|
2025-12-01 | $0 | M | Form 4 |
|
STOK
M
Stoke Therapeutics, Inc.
Ticho Barry
• Officer • CHIEF MEDICAL OFFICER
Equity Compensation
2025-12-01
$0
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • CHIEF MEDICAL OFFICER
Equity Compensation
|
2025-12-01 | $0 | M | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Krainer Adrian R.
• Director
10b5-1 SellΔOwn -11.1%
2025-11-24
$1,202,719Large
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Director
10b5-1 SellΔOwn -11.1%
|
2025-11-24 | $1,202,719Large | S | Form 4 |
| STOK |
Stoke Therapeutics, Inc.
|
Director
10b5-1 Sell
|
2025-11-14 | $526,693 | S | Form 4 |
| STOK |
Stoke Therapeutics, Inc.
|
Director
10b5-1 Sell
|
2025-11-14 | $565,365 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Ticho Barry
• Officer • CHIEF MEDICAL OFFICER
10b5-1 Sell
2025-11-03
$2,935
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • CHIEF MEDICAL OFFICER
10b5-1 Sell
|
2025-11-03 | $2,935 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Ticho Barry
• Officer • CHIEF MEDICAL OFFICER
10b5-1 SellΔOwn -15.6%
2025-11-03
$37,860
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • CHIEF MEDICAL OFFICER
10b5-1 SellΔOwn -15.6%
|
2025-11-03 | $37,860 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Ticho Barry
• Officer • CHIEF MEDICAL OFFICER
10b5-1 SellΔOwn -28.8%
2025-11-03
$95,247
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • CHIEF MEDICAL OFFICER
10b5-1 SellΔOwn -28.8%
|
2025-11-03 | $95,247 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Ticho Barry
• Officer • CHIEF MEDICAL OFFICER
10b5-1 Sell
2025-11-03
$16,524
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • CHIEF MEDICAL OFFICER
10b5-1 Sell
|
2025-11-03 | $16,524 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Kaye Edward M. MD
• Director
10b5-1 SellΔOwn -33.7%
2025-10-08
$750,000
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Director
10b5-1 SellΔOwn -33.7%
|
2025-10-08 | $750,000 | S | Form 4 |
| STOK |
Stoke Therapeutics, Inc.
|
Director
Other
|
2025-10-08 | $15,000 | M | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
10b5-1 SellΔOwn -45.8%
2025-10-03
$250,650
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
10b5-1 SellΔOwn -45.8%
|
2025-10-03 | $250,650 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Kaye Edward M. MD
• Director
10b5-1 SellΔOwn -46.4%
2025-10-03
$1,065,206Large
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Director
10b5-1 SellΔOwn -46.4%
|
2025-10-03 | $1,065,206Large | S | Form 4 |
|
STOK
M
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
Other
2025-10-03
$91,500
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
Other
|
2025-10-03 | $91,500 | M | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Ticho Barry
• Officer • CHIEF MEDICAL OFFICER
10b5-1 SellΔOwn -28.9%
2025-10-01
$126,316
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • CHIEF MEDICAL OFFICER
10b5-1 SellΔOwn -28.9%
|
2025-10-01 | $126,316 | S | Form 4 |
| STOK |
Stoke Therapeutics, Inc.
|
Director
Equity Compensation
|
2024-12-01 | $0 | M | Form 4 |